High Risk Localised Prostate Carcinoma
2 clinical trials · Condition
◉ Watch High Risk Localised Prostate Carcinoma
| Record | Firm | Date |
|---|---|---|
| Addition of Focal Boost to Primary Radiotherapy for Prostate Cancer in 12 or 20 Fractions (NCT07343349) | Rigshospitalet, Denmark | 2025-12-15 |
| Neo-adjuvant Abiraterone Prostate Study (NCT02160353) | Cancer Trials Ireland | 2015-07-09 |
Track High Risk Localised Prostate Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.